ShortCuts-This Week in the Journals

June 9, 2008
ShortCuts-This Week in the Journals

Commentary by Neil Shapiro MD, Editor-in-Chief, Clinical Correlations

Spiking oil prices, unemployment at 5.5%, Israel considering bombing Iran, 95 degree heat in early June, the White House exaggerating the case to go to war…the news was just tremendously uplifting this week. At least the democrats seem to be getting their act together. Sorry to start ShortCuts on a downer, but I thought maybe what follows could be seen as a reprieve from the news, where you can spend a moment not cursing the…

Read more »

HotSpots: Wave-maven, Clinical Trial Results and Gold Miner

June 6, 2008
HotSpots: Wave-maven, Clinical Trial Results and Gold Miner

Welcome to HotSpots. In this series, we highlight unique websites of interest to the medical profession. Feel free to make suggestions for sites that should be featured in this series by clicking the comment field or sending us an email.

Commentary by Rachana Jani MD, PGY-1

 

Wave-maven

http://ecg.bidmc.harvard.edu/maven/mavenmain.asp

Every physician needs to be proficient in ECGs – and Dubin can only get you so far. Wave-maven is a great site for hundreds of ECG clinical cases designed to go beyond the…

Read more »

Grand Rounds: “Nephrogenic systemic fibrosis”

June 5, 2008
Grand Rounds: “Nephrogenic systemic fibrosis”

Commentary by Jatin Roper MD, PGY-3

Medical Grand Rounds today was presented last week by Dr. Shawn Cowper, Assistant Professor of Dermatology and Pathology at Yale University School of Medicine. Grand Rounds began with the presentation of a case from Tisch Hospital:

A 46 year old female with a history of end-stage renal disease secondary to diffuse-proliferative glomerulonephritis on hemodialysis, systemic lupus erythematosis, antiphospholipid antibody syndrome, and IVC thrombosis presents to a dermatology consultant for progressive hardness, tightness, and tenderness…

Read more »

Pharmaceutical industry marketing to physicians: what’s the big deal?

June 4, 2008
Pharmaceutical industry marketing to physicians: what’s the big deal?

Commentary by Jatin Roper, MD, PGY3, NYU Internal Medicine and Nitin Roper, MSIII, University of Connecticut School of Medicine

Pharmaceutical companies play a vital role in improving the public health through drug discovery. These for-profit entities are in the business of selling their products to physicians and patients. If you’re a physician, the images of drug marketing are ubiquitous: the attractive, vivacious sales representative who always seems happy to see you; the sea of purple tote bags at the last national gastroenterology meeting…

Read more »

ShortCuts-This Week in the Journals

June 2, 2008
ShortCuts-This Week in the Journals

Commentary by Henry Tran, MD

Opiate-induced constipation is frequently encountered by hospitalized patients. As Ben Franklin said, “An ounce of prevention is worth a pound of cure,” therefore an aggressive bowel regiment of stool softeners and laxatives will often prevent this problem from becoming a serious one. Not shockingly conventional bowel regiments sometimes don’t work and clinicians must resort to other treatments. Oral naloxone (Narcan) in escalating doses has been shown to be a successful treatment for opiate-induced constipation and even for post-op…

Read more »

Approach to a Patient with ‘Treatment Refractory’ Depression in The Medical Setting: Part 2

May 29, 2008
Approach to a Patient with ‘Treatment Refractory’ Depression in The Medical Setting: Part 2

Commentary by Brian Bronson, MD, Chief of Psychosomatic Medicine, VA New York Harbor, New York Campus

Summary: Symptoms of depression in the medical setting may not respond to usual pharmacologic antidepressant treatment for a number of reasons. These may include an incorrect psychiatric diagnosis; failure to consider underlying medical causes of the symptoms; or insufficient antidepressant medication trial due to poor patient adherence, insufficient dose or length of trial. There is no consensus as to the definition of ‘treatment refractory’ depression. However,…

Read more »

ShortCuts-This Week in the Journals

May 28, 2008
ShortCuts-This Week in the Journals

Commentary by Josh Olstein MD, NYU Chief Resident 

This week’s edition of shortcuts begins with an article from the NEJM looking at the role of cardiac troponin in patients with acute decompensated heart failure. Many of us have “cycled the trops” countless times to evaluate patients with chest pain. However the utility of troponin measurement in patients with CHF is less clear. In this study the authors examined short-term outcomes of patients admitted with CHF exacerbations that had troponin data available on…

Read more »

Riegel v. Medtronic: Vaccination Against Medical Device Liability?

May 24, 2008
Riegel v. Medtronic: Vaccination Against  Medical Device Liability?

Commentary by Sandeep Mangalmurti MD, JD PGY-2

It is difficult to overstate the importance of the Supreme Court’s recent decision in Riegel v. Medtronic the first of a series of cases that may fundamentally alter medical liability lawsuits for decades to come.

The case involves Charles Riegel, who in 1996 suffered complications secondary to coronary angioplasty. During the procedure, the angioplasty balloon burst, and the patient required emergent coronary artery bypass graft to save his life. He later sued Medtronic, the…

Read more »